Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Derma X ApS
APS
Active
CVR 44546841
Amager Strandvej 418, st. 4
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2024
1 employees
www.derma-x.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 704K
EBITDA margin
94.6%
Equity ratio
50.4%
Financial strength
Net profit 2025
DKK 409K
1 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2025
Key figures
Annual report 2025
Revenue
DKK 704K
—
EBITDA
DKK 666K
—
Net profit
DKK 409K
—
Total assets
DKK 891K
—
Equity
DKK 449K
—
Employees
1
—
Company information
Legal name
Derma X ApS
CVR number
44546841
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. januar 2024
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør alene.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning til dette.
Contact
Address
Amager Strandvej 418, st. 4
Phone
+4530200214
Email
info@derma-x.dk
Website
www.derma-x.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Tårnby
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2025
Income statement
DKK thousands
Item
2025
Revenue
704
Staff expenses
-15
EBITDA
666
Depreciation & amort.
-144
EBIT
522
Net financials
-13
Profit before tax
509
Tax
100
Net profit
409
Balance sheet
DKK thousands
Item
2025
Total assets
891
Equity
449
Long-term debt
0
Short-term debt
442
Total debt
442
Financial ratios
5-year trend
EBITDA margin
94.6%
This company
15.8%
Market median
+499% vs market
2025
2025
Equity ratio
50.4%
This company
38.2%
Market median
+32% vs market
2025
2025
Return on equity
91.1%
This company
18.4%
Market median
+395% vs market
2025
2025
Net profit margin
58.1%
This company
8.1%
Market median
+617% vs market
2025
2025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
2025
2025
Debt / equity
0.98×
This company
0.62×
Market median
+58% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-01-08 – 2025-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MG
Mohamad Grøn Al-Khatib
Chief Executive Officer
Chief Executive Officer
2026
—
—
MN
Marc Nouri Genning
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Zen Holding ApS
Company
100.0%
100.0%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Zen Holding ApS
Derma X ApS
(this company)
Board network connections
Board members of Derma X ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mohamad Grøn Al-Khatib
Chief Executive Officer
0 companies
Marc Nouri Genning
Chief Executive Officer
0 companies